Follow us on Twitter
twitter icon@FreshPatents


Dimethyl patents

      

This page is updated frequently with new Dimethyl-related patent applications.




 Methods, compositions, and systems for activation and expansion of cells patent thumbnailMethods, compositions, and systems for activation and expansion of cells
The disclosure provides for compositions, systems, and methods of cell expansion, stimulation and/or differentiation. The disclosure further provides for a mesh substrate and associated methods capable of stimulating cell expansion, for example, t cell or stem cell expansion.
The Trustees Of Columbia University In The City Of New York


 Thermoplastic polyurethane composition for injection molding and  manufacturing the same patent thumbnailThermoplastic polyurethane composition for injection molding and manufacturing the same
The present invention provides a thermoplastic polyurethane composition for injection molding and a method of manufacturing the same. The thermoplastic polyurethane composition for injection molding can be easily injection-molded since a slip property is imparted to a soft segment, and can possess excellent durability properties such as heat-aging resistance, photoaging resistance, and wear resistance, and stability properties such as airbag deployment performance and anti-fogging property, as well as excellent tactile sensation and embossing quality, when a chain extender and a multifunctional polydimethylsiloxane-based compound are mixed with an isocyanate- and ether-containing polyester polyol, and can be useful in simplifying processes, reducing manufacturing costs, and simplifying facilities due to a decrease in the number of parts when molded articles are manufactured using the composition..
Hyundai Mobis Co., Ltd.


 Antibacterial 1h-indazole and 1h-indole derivatives patent thumbnailAntibacterial 1h-indazole and 1h-indole derivatives
Wherein a is a bond, ch2ch2, ch═ch or c≡c; r1a is h or halogen; r2a is h, alkoxy or halogen; r3a is h, alkoxy, hydroxyalkoxy, alkoxyalkoxy, thioalkoxy, trifluoromethoxy, amino, hydroxyalkyl, 2-hydroxyacetamido, 1-aminocyclopropyl, 1-hydroxymethyl-cycloprop-1-yl, 1-((phosphonooxy)methyl)cyclopropyl, 1-(((dimethylglycyl)oxy)methyl)cyclopropyl, trans-2-hydroxymethyl-cycloprop-1-yl, 1,2-dihydroxyethyl, 3-hydroxyoxetan-3-yl, 3-(hydroxyalkyl)oxetan-3-yl, 3-aminooxetan-3-yl, 3-hydroxythietan-3-yl, morpholin-4-ylalkoxy, morpholin-4-yl-alkyl, oxazol-2-yl or [1,2,3]triazol-2-yl; and r1b is hydroxyalkyl, dihydroxyalkyl, aminoalkyl, 1-hydroxymethyl-cycloprop-1-yl, 1-aminomethyl-cycloprop-1-yl, trans-2-hydroxymethyl-cycloprop-1-yl, 3-hydroxyoxetan-3-yl, 3-hydroxythietan-3-yl, 1-(2-hydroxyacetyl)azetidin-3-yl, 1-(2-aminoacetyl)azetidin-3-yl, 1-glycylazetidin-3-yl, 1-(2-amino-2-methylpropanoyl)azetidin-3-yl, 3-(2-aminoacetamido)cyclopentyl, trans-(cis-3,4-dihydroxy)-cyclopent-1-yl or 3-hydroxymethylbicyclo[1,1,1]pentan-1-yl; and salts thereof.. .

 Compositions for the treatment of cataracts patent thumbnailCompositions for the treatment of cataracts
In one embodiment, the present application discloses an aqueous ophthalmic composition for the treatment of eye diseases, lesions and injuries, comprising: a) one steroid, or a combination of at least two steroids selected from the group consisting of lanosterol, dihydrolanosterol, 4,4-dimethylcholesta-8(9),14,24-trien-3β-ol, 4,4-dimethylcholesta-8,24-dien-3β-ol, 4,4-dimethylcholesta-8-en-3β-ol, 4,4-dimethylcholesta-8(9),14-dien-3β-ol, 14-desmethyl lanosterol, lathosterol, Δ7,24-cholestadienol, cholesterol, cholesta-7-enol, cholesteryl ester, 7-dehydrocholesterol, desmosterol, 7-dehydrodesmosterol, zymosterol, 27-hydroxycholesterol, cholesta-7,24-dien-3-β-ol, cholesta-8(9)-en-3-β-ol, 5α-cholestan-3β-ol-6-one, 5-cholesten-3β,25-diol, 5-cholesten-3β,25-oso3h (5-cholesten-3β,25-sulfate), 5-cholesten-3β-oso3h,25-ol (5-cholesten-3β-sulfate,25-ol), 5-cholesten-3β,25-diol, disulfate, and their esters thereof, or a pharmaceutically acceptable salt thereof, in a concentration effective for the treatment and/or prophylaxis of the eye diseases, lesions and injuries; and b) a pharmaceutical excipient; and methods of treatment using such compositions.. .
Catacore, Inc.


 Combination patent thumbnailCombination
The present invention relates to a method of treating breast cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a breast cancer treatment method that includes administering 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and (s)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1h-pyrano[3′,4′:6,7] indolizino [1,2-b]quinoline-3,14-(4h,12h)-dione, or a pharmaceutically acceptable salt thereof, to a human in need thereof..
Sunnybrook Research Institute


 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones patent thumbnailSubstituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
Disclosed are substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-one compounds, pharmaceutical compositions comprising at least one such 4 substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-one compound processes for the preparation thereof, and the use thereof for inhibiting bet family of bromodomains and for treating disorders mediated thereby, such as certain cancers.. .
Beigene, Ltd.


 Methods for fractionating lipids patent thumbnailMethods for fractionating lipids
[means for solving] to provide a method for fractionating a lipid using liquefied dimethyl ether as a solvent. [solution] a method for fractionating a lipid, which comprises subjecting a microbial biomass to extraction using liquefied dimethyl ether as a solvent and then fractionating the lipid utilizing separation selectivity for the lipid.

 High heat polycarbonate compositions patent thumbnailHigh heat polycarbonate compositions
Metallized articles comprising polycarbonate compositions are disclosed. The compositions include at least one first polycarbonate useful for high heat applications, a second polycarbonate that is a bisphenol a (bpa) polycarbonate-polydimethyl-siloxane copolymer; and optionally a third polycarbonate.
Sabic Global Technologies B.v.


 Aromatic polyamide films for transparent flexible substrates patent thumbnailAromatic polyamide films for transparent flexible substrates
The present invention is directed toward transparent films prepared from soluble aromatic copolyamides with glass transition temperatures greater than 300 c. The copolyamides, which contain pendant carboxylic groups are solution cast into films using n,n-dimethylacetamide (dmac), n-methyl-2-pyrrolidinone (nmp), or other polar solvents.
Akron Polymers Systems, Inc.


 Natural and synthetic compounds for treating cancer and other diseases patent thumbnailNatural and synthetic compounds for treating cancer and other diseases
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, cns, melanoma, renal, cervical, esophageal, testicular, spleenic, kidney, lymphatic, pancreatic, stomach and thyroid cancers. This invention is an anti-adhesion therapy which uses the compound as a mediator or inhibitor of adhesion proteins and angiopoietins.
Pacific Arrow Limited


Ethanol production via dimethylether recycle

This invention relates to a process for producing ethanol comprises supplying a feed comprising carbon monoxide, hydrogen and dimethyl ether to a reaction zone operated under conditions such that (i) part of the carbon monoxide in the feed reacts with part of the hydrogen in the feed to produce methanol; (ii) part of the carbon monoxide in the feed reacts with at least part of the dimethyl ether in the feed to produce methyl acetate; and (iii) part of the hydrogen in the feed reacts with at least part of the methyl acetate produced in (ii) to produce an effluent comprising methanol and ethanol. At least part of the ethanol is recovered from the effluent and at least part of the methanol is dehydrated to produce dimethyl ether, which is recycled to the reaction zone..
Exxonmobil Chemical Patents Inc.

Treatment of cervical cancer with gold(i) complexes

Gold(i) complexes of formulae [au{p(t-bu)3}(s2cn(ch3)2)] (1), and [au{p(t-bu)3}(s2cn(c2h5)2)] (2) have been prepared by the reaction of equimolar amounts of [au{p(t-bu)3}(cl)] with sodium dimethyldithiocarbamate monohydrate, and sodium diethyldithiocarbamate trihydrate respectively. Both complexes (1) and (2) are iso-structural having linear geometry.
King Abdulaziz City For Science And Technology

Treatment and composition for achieving skin anti-aging benefits by corneum protease activation

Novel methods and compositions for treating aged and environmentally damaged skin are disclosed which provide improvements in the skin's visual appearance, function and clinical/biophysical properties by activating at least one proteolytic enzyme in the skin's stratum corneum. The disclosed treatment methods involve topical application of a novel cosmetic composition containing a combination of a cationic surfactant such as n,n,-dimethyldodecyl amine oxide (dmdao), an anionic surfactant such as sodium dodecyl sulfate (sds), or monoalkyl phosphate (map) and a chelating agent such as ethylene diamine tetraacetate (edta) to stimulate a chronic increase in the replacement rate of the skin's stratum corneum by means of corneum protease activation.
Mary Kay Inc.

Enhancement solution for enhancing chemiluminescence and preparing chemiluminescent solution

Disclosed are an enhancement solution for enhancing chemiluminescence, and a method for preparing a chemiluminescent solution. The method comprises step a: dissolving methylglucamine in water, adjusting the ph to 8-9, then adding an n-alkyldimethylmannosamine quaternary ammonium salt, acridine orange, bsa, glycine, mgcl2, and zncl2 respectively to a diethanolamine solution, stirring to dissolve them, and diluting to a constant volume, to obtain an enhancement solution; and step b: diluting a chemiluminescent substrate with the enhancement solution, to obtain a chemiluminescent solution.
Shenzhen Maxchemtech Co., Ltd.

Method for preparing polycarbosilane by catalytic rearranging

This invention provides a method for preparing a polycarbosilane by decomposition and rearrangement a cyclic silane compound or chain polysilane under the catalysis of a boron-containing catalyst in a trace amount (less than 1 wt %). In the method, poly(dimethylsilane) (denoted as pdms) or a thermal decomposition product thereof, i.e., a liquid silane-carbosilane compound (denoted as lps), is used as the raw material, less than 1 wt % of the boron-containing catalyst (with respect to the amount of the raw material) is added, and then the temperature is gradually increased to the reaction temperature under atmospheric pressure or high pressure to perform the thermal decomposition/rearrangement reaction so as to obtain solid polycarbosilane (pcs) with a higher ceramic yield.
Institute Of Chemistry, Chinese Academy Of Science

Novel compounds

The invention is directed to certain novel compounds. Specifically, crystalline forms of n-[5-[4-(5-{[(2r,6s)-2,6-dimethyl-4-morpholinyl]methyl}-1,3-oxazol-2-yl)-1h-indazol-6-yl]-2-(methyloxy)-3-pyridinyl]methanesulfonamide and crystalline 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole, along with salts thereof..
Glaxo Group Limited

Cyclopropene amino acids and methods

The invention relates to a polypeptide comprising an amino acid having a cyclopropene group wherein said cyclopropene group is joined to the amino acid via a carbamate group. Suitably the cyclopropene group is a 1,3-disubstituted cyclopropene such as a 1,3-dimethylcyclopropene.
Medical Research Council

Method for the synthesis of supported gold (au) nanoparticles for epoxidation reactions

Processes for preparing supported gold nanoparticle catalysts are provided. In an exemplary embodiment, the process includes adding a solution of a phosphorus compound to a solution of chloro (dimethyl sulfide) gold (i) to obtain a solution of chloro (phosphorus compound) gold (i) complex, adding the solution of chloro (phosphorus compound) gold (i) complex to a solution of silver nitrate to obtain a solution of nitro (phosphorus compound) gold (i) complex, applying the solution of nitro (phosphorus compound) gold (i) complex to a metal hydroxide support, drying the metal hydroxide support; and calcining the dried metal hydroxide support to form the supported gold nanoparticle catalyst.
Sabic Global Technologies B.v.

Anti-fouling membranes

A membrane assembly is provided. The membrane assembly comprises a membrane having a first surface and an opposing second surface, and a layer of anti-fouling polymer selected from the group consisting of an optionally functionalized hyperbranched polyglycerol, a hyperbranched polyimine, a zwitterionic copolymer obtainable by polymerizing 2-methacryloyloxyethyl lipoate with at least one of [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl) ammonium hydroxide or 2-methacryloyloxyethylphosphorylcholine, and combinations thereof arranged on the first surface of the membrane.
National University Of Singapore

Agent for sedating response to external stimulation in skin and sedating that response

An object of the present invention is to provide an agent for sedating the response of skin to external stimulation. The aforementioned object was achieved by finding a component that promotes cd39 gene expression in langerhans cells.
Shiseido Company, Ltd

Electric double-layer capacitor

An electric double-layer capacitor contains an electrolytic solution, wherein the electrolytic solution comprises 1.2 to 1.8 mol/l of spirobipyrrolidinium tetrafluoroborate as electrolyte as well as solvent, where the solvent contains 50 to 60 percent by volume of propylene carbonate, 30 to 36 percent by volume of dimethyl carbonate, and 4 to 20 percent by volume of ethyl methyl carbonate. The electric double-layer capacitor can maintain its initial high capacitance and low internal resistance, while undergoing smaller characteristic changes after being exposed to low-temperature environments, high-voltage environments or high-temperature environments..
Taiyo Yuden Co., Ltd.

In-situ heated deposition of parylene to enhance pore penetration into silicone

A composition of matter is described in which a porous material, such as polydimethylsiloxane (pdms), is coated with parylene n, c, d, or af-4 by vapor deposition polymerization while a temperature of the porous material's surface being coated is heated to between 60° c. And 120° c., or 80° c.
California Institute Of Technology

Anti-fog compositions and processes for making same

Anti-fog compositions comprising a primary film having opposing major planar surfaces and a central coplanar region disposed between the opposing major planar surfaces and comprising cellulose acetate and a plasticizer. The cellulose acetate may have a degree of substitution less than 2.6.
Celanese International Corp.

Spiral-type separation membrane element

The objective of the present invention is to provide a spiral-type separation membrane element having superior oxidant resistance relative to the prior art, and a salt-blocking rate that tends not to decrease. The spiral-type separation membrane element is characterized in including: a supply-side flow-path material; a composite semipermeable membrane in which a skin layer is formed on the surface of a porous support, the skin layer containing a polyamide resin obtained by interfacial polymerization of a polyfunctional amine component and a polyfunctional acid halogen component; and a permeation-side flow-path material, wherein the polyfunctional amine component contains n,n′-dimethyl-meta-phenylenediamine and the permeation-side flow-path material has a porosity of 40 to 75%..
Nitto Denko Corporation

Stable veterinary anthelmintic formulations

Described herein are stable veterinary formulations and methods of treatment and use, comprising at least one macrocyclic lactone and levamisole as active anthelmintic agents, optionally also with at least one benzimidazole class anthelmintic, wherein the actives are solubilised together in a solvent system comprising dimethylsulfoxide (dmso). The veterinary formulations, methods and use thereof include the ability to deliver two or more anthelmintic actives in the one solution (or suspension) whilst also maintaining formulation stability when stored over a period of time.
Donaghys Limited

Anhydrous antiperspirant composition in aerosol form comprising an antiperspirant active agent and a water-insoluble film-forming block ethylenic polymer

Anhydrous antiperspirant composition in aerosol form comprising an antiperspirant active agent and a water-insoluble film-forming block ethylenic polymer the present invention relates to an anhydrous composition in aerosol form containing: i) an oily phase comprising, in a physiologically acceptable medium: —at least one volatile oil, and —one or more antiperspirant active agents chosen from aluminium and/or zirconium salts, and —one or more water-insoluble film-forming block ethylenic polymers comprising a first block with a glass transition temperature (tg) of greater than or equal to 85° c. And a second block with a tg of less than or equal to 20° c., and ii) one or more propellants; the said oily phase containing less than 15% by weight and even more preferably less than 12% by weight of non-volatile polydimethylsiloxane relative to the total weight of the oils.
L'oreal

Composition for preparing a polymeric foam

The present invention relates to composition for the preparation of a polymeric foam with improved thermal properties, to a polymeric foam obtainable therefrom, and to a method for preparing such a polymeric foam each for them comprising (i) an at least essentially amorphous polymer resin and (ii) a nucleating agent. The at least essentially amorphous polymer resin is preferably polystyrene.
Clariant International, Ltd.

Terephthalate derivatives and compositions thereof

The present invention provides dimethylterephthalate in which two of the aromatic ring carbons are derived from ethanol. The present invention also provides bis (2-hydroxyethyl) terephthalate, wherein two to six carbon atoms in a molecule can be derived from ethanol..

Method for synthesising dimethyl carbonate

A method for synthesising dimethyl carbonate from methanol and urea, in which a saline ureic medium is used that includes at least one inorganic salt selected from the group made up of zinc (zn) (ii) chloride, tin (sn) chlorides and iron (fe) (iii) chloride, characterised in that: methanol, in the presence of a catalytic composition, is placed in contact with the saline ureic medium that is at least partially liquid at a temperature referred to as synthesis temperature, which is higher than 140° c., such that reaction vapours are produced; the reaction vapours are condensed, and a condensate of the reaction vapours is collected, including dimethyl carbonate; the method is carried out at atmospheric pressure. A method for enriching and purifying dimethyl carbonate is also described..
Institut National De La Recherche Agronomique

Method for preparing polyoxymethylene dimethyl ether carbonyl compound and methyl methoxyacetate

A method for preparing a polyoxymethylene dimethyl ether carbonyl compound and/or methyl methoxyacetate as intermediates for producing ethylene glycol, which comprises passing a raw material: polyoxymethylene dimethyl ether or methylal together with carbon monoxide and hydrogen gas through a reactor carrying an acidic molecular sieve catalyst, and performing a reaction to prepare a corresponding product under an appropriate condition where no other solvent is added, in which the process of the reaction is a gas-liquid-solid three-phase reaction, the raw material of polyoxymethylene dimethyl ether or methylal has a high conversion rate, each product has a high selectivity, the catalyst has a long service life, additional solvents are not required to be used, and reaction conditions are relatively mild.. .
Dalian Institute Of Chemical Physics, Chinese Academy Of Sciences

Process of production of 2,5-dimethylphenol

The present invention relates to a new method to produce 2,5-dimethylphenol (2,5-dmp).. .
Dsm Ip Assets B.v.

Non-invasive monitoring cancer using integrated microfluidic profiling of circulating microvesicles

A microfluidic exosome profiling platform integrating exosome isolation and targeted proteomic analysis is disclosed. This platform is capable of quantitative exosomal biomarker profiling directly from 30 μl plasma samples within approximately 100 minutes with markedly enhanced sensitivity and specificity.

Reaction device for preparing light olefins from methanol and/or dimethyl ether

A reaction device for preparing light olefins from methanol and/or dimethyl ether, and more specifically relates to a reaction device for preparing light olefins from methanol and/or dimethyl ether, which mainly comprises a dense phase fluidized bed reactor (2), a cyclone separator (3), a stripper (5), a lift pipe (7), a dense phase fluidized bed regenerator (10), a cyclone separator (11), a stripper (13), and a lift pipe (15), wherein the dense phase fluidized bed reactor (2) is separated into n (n≧2) secondary reaction zones by a material flow controller (17), and the dense phase fluidized bed regenerator (10) is separated into m (m≧2) secondary regeneration zones by the material flow controller (17).. .
Dalian Institute Of Chemical Physics, Chinese Academy Of Sciences

Dimethyl fumarate and vaccination regimens

Provided herein is a method of treating or preventing a disease or disorder (e.g., ms) in a subject in need thereof, comprising (a) administering to the subject a first dose of a pharmaceutical composition comprising a fumarate agent (e.g., dmf) for a first dosing period; (b) administering a vaccine; and (c) administering to the subject a second dose of the pharmaceutical composition for a second dosing period.. .
Biogen Ma Inc.

Antifungal compositions for the treatment of skin and nails

The invention concerns a composition and method for treating an ungual infection, the composition comprising an iodophor and dimethylsulfoxide (dmso).. .
Veloce Biopharma, Llc

Pharmaceutical composition including 5--2,2-dimethyl-4-(3-fluorophenyl)-3(2h)-furanone and capsule formulation including the pharmaceutical composition

The present invention relates to a pharmaceutical composition including (i) the compound of formula 1 described in the specification or a pharmaceutically acceptable salt thereof, (ii) a pharmaceutically acceptable diluent, and (iii) a pharmaceutically acceptable lubricant. The compound of formula 1 or pharmaceutically acceptable salt thereof has a 50% volume particle diameter (d(0.5)) of 3 μm to 9 μm.
Crystalgenomics, Inc.

Lyophilized pharmaceutical compositions

The invention provides a method of preparing a lyophilized pharmaceutical composition containing a compound described herein or a pharmaceutically-acceptable salt thereof. The process comprises dissolving the compound in a solvent comprising dimethylsulfoxide and optionally one or more co-solvents to form a solution, and then removing the solvent and any co-solvents by a freeze-drying process.
Astex Pharmaceuticals, Inc.

Electrochromic thermoplastics, devices, and composites

An electrochromic thermoplastic composition includes about 10 wt % to about 60 wt % a poly(vinyl alcohol), a poly(acrylic acid), a poly(acrylic acid) salt, a polyaniline salt, a poly(diallyl dimethyl ammonium chloride), a poly(ethylene-co-acrylic acid), a co-polymer of any two or more thereof, or a mixture of any two or more thereof; about 40 wt % to about 90 wt % of a protic solvent; and at least one electroactive material; wherein the composition does not include lithium chloride, tetrabutylammonium bromide, lithium bis(trifluoromethanesulfonyl)imide, lithium triflate, and lithium hexafluorophosphate.. .
Gentex Corporation

Perfume composition

Provided is a fragrance composition containing a compound that has citrus and green odors as well as a floral-like odor in good balance, has excellent harmonicity with various other fragrances, emphasizes odors by being blended, and imparts a fresh floral feeling. A fragrance composition containing 4,7-dimethyloctan-3-ol.
Kao Corporation

Polylactic acid (pla) with low moisture vapor transmission rates by grafting through of hydrophobic polymers directly to pla backbone

Polylactic acid-backbone graft and bottlebrush copolymers with low moisture vapor transmission rates are synthesized by polymerizing a lactide-functionalized hydrophobic macromonomer using ring-opening polymerization (rop). In some embodiments of the present invention, the macromonomer is a lactide-functionalized hydrophobic polymer that may be synthesized by, for example, polymerizing a hydrophobic monomer (e.g., a fluorinated vinyl monomer such as 2,2,2-trifluroethyl methacrylate) capable of undergoing radical polymerization (e.g., styrenic, vinylic, acrylic, etc.) using a brominated lactide initiator via atom transfer radical polymerization (atrp).
International Business Machines Corporation

Etoposide and doxorubicin conjugates for drug delivery

The invention relates to improvements in the field of drug delivery. More particularly, the invention relates to polypeptides having a hydrolyzable covalent bond to a therapeutic agent that includes, etoposide, etoposide 4′-dimethylglycine or doxorubicin.
Angiochem Inc.

Nonaqueous electrolytic solution for electric double layer capacitor

Provided is a nonaqueous electrolytic solution that provides an electric double layer capacitor having excellent durability. The nonaqueous electrolytic solution is prepared by dissolving a quaternary ammonium salt as an electrolyte in a nonaqueous solvent, and the nonaqueous electrolytic solution comprises a diethylpyrrolidinium salt and/or a 1-ethyl-1,3-dimethylpyrrolidinium salt..
Otsuka Chemical Co., Ltd.

Fuel and process for powering a compression ignition engine

A diesel engine fuel composition including methanol, at least 5% by weight water, one or more additives selected from the group consisting of: ignition improvers, fuel extenders, combustion enhancers, oxygen absorbing oil, lubricity additives, product colouration additives, flame colour additives, anti corrosion additives, biocides, freeze point depressants, deposit reductants, denaturants, ph controlling agents, and mixtures thereof, and 0% to 20% by weight dimethyl ether. Also provided is a process of powering a compression ignition engine using such a diesel engine fuel..
Gane Energy & Resources Pty Ltd.



Dimethyl topics:
  • Physiologic
  • Hydrochloric Acid
  • Fresnel Zone
  • Aberration
  • Ophthalmic
  • Liquid Crystal
  • Imaging System
  • Pharmaceutically Acceptable Salt
  • Pharmaceutically Acceptable Salts
  • Chloric Acid
  • Tartaric Acid
  • Fumaric Acid
  • Antagonist
  • Bradykinin
  • Enantiomer


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.


    1.2187

    file did exist - file did put2242

    4 - 1 - 50